͵͵

Journal News

From the Journals: MCP

Indumathi Sridharan
By Indumathi Sridharan
Aug. 30, 2024

A deep learning approach to phosphoproteomics. Untangling complex proteomics mass spec data. Read about papers on these topics recently published in the journal ͵͵ & Cellular Proteomics.

 

A deep learning approach to phosphoproteomics

An example of a phosphorylated protein; X-ray structure of an active ERK2 kinase. The phosphorylated threonine and tyrosine residues are highlighted in red.
Bubus, CC BY-SA 3.0 / Wikimedia Commons
An example of a phosphorylated protein; X-ray structure of an active ERK2 kinase. The phosphorylated threonine and tyrosine residues are highlighted in red.

The post-translational modification known as phosphorylation regulates numerous cellular functions, including cell growth, movement and metabolism. Phosphoproteomics, the study of phosphorylated proteins, offers valuable insights into dynamic changes in signaling pathways mediated by phosphorylation. Phosphoproteomics relies on mass spectrometry and computational methods to detect phosphorylated sites within a protein sequence. However, accurate detection is challenging due to the transient nature and low abundance of phosphorylated peptides relative to the proteome. Moreover, different computational methods yield varying outcomes, thus undermining confidence in the results.

In a recent published in ͵͵ & Cellular Proteomics, Xinpei Yi and colleagues from Baylor College of Medicine and the Liver Cancer Institute at Fudan University employed deep learning to enhance phosphoproteomics accuracy. Deep learning is an artificial intelligence method that discerns patterns from vast amounts of unstructured data using neural networks.

Yi and collaborators used a multifaceted approach that included deep-learning algorithms for predicting peptide retention time and fragment ion intensity, a statistical scoring algorithm that integrates these deep-learning predictions for determining the probability of a site being phosphorylated, and a machine learning algorithm that also integrates the deep learning predictions for identifying peptides based on theoretical spectra. Compared to standalone algorithms, this integrative approach, named DeepRescore2, identified more phosphorylated peptides in synthetic and biological data sets from normal and liver cancer tissues.  

Accurately identifying phosphopeptides can aid in precise inference of the activity of kinases, which drive phosphorylation. The authors used DeepRescore2 to infer activity of epidermal growth factor receptor kinase, a biomarker of liver cancer. DeepRescore2 correctly inferred high kinase activity in liver cancer samples from patients with poor prognoses. The combinatorial deep learning approach used in the study enables accurate profiling of phosphoproteins and may serve as a prognostic tool. Combining DeepRescore2 with other algorithms enables more precise detection of phosphorylation activity, thus paving the way for biomarker-guided cancer therapies.

Untangling complex proteomics mass spec data

Data-independent acquisition, or DIA, is a popular technique used to analyze proteomes by mass spectrometry, or MS. In DIA, all detectable ions from a proteomics sample are iteratively analyzed, much like observing a crowded street one angle at a time. Despite the broad coverage and sensitivity DIA provides, its application is limited due to the difficulty in discerning similar molecules with overlapping signals in a complex sample.

In a recent  published in the journal ͵͵ & Cellular Proteomics, Sophia Steigerwald at the Max Planck Institute of Biochemistry and colleagues combined DIA with an advanced signal processing method, the phase–constrained spectrum deconvolution method, or ΦSDM, to tackle the challenge of complex spectra. The ΦSDM method imposes mathematical constraints based on the phase information of peptide ions to untangle overlapping signals within a mass spectrum. The authors tested the ΦSDM–DIA approach using HeLa cells.

By implementing ΦSDM signal processing on additional graphics processing units, the researchers quickly achieved a higher signal-to-noise ratio and 15% more peptide coverage compared to conventional methods, particularly in samples with short gradient times. Thus, advanced analytical techniques such as ΦSDM–DIA may help unravel unknown cellular pathways and events driven by complex proteomes or transient proteins without compromising on speed, quality and accuracy.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Indumathi Sridharan
Indumathi Sridharan

Indumathi (Indu) Sridharan holds a Ph.D. in molecular biochemistry and did her postdoctoral work in bionanotechnology at Northwestern University. She currently works at the intersection of clinical trials, data and digital technology as a product lead at Medidata AI. She is an ASBMB Today volunteer contributor.

Related articles

From the journals: MCP
Vanshika Patel
From the journals: MCP
Krishnakoli Adhikary
From the journals: MCP
Naushin Raheema
From the journals: MCP
Nivedita Uday Hegdekar

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.